Robo Monthly
Global retrospective · April 2026
Monthly thesis
Public trials expose real-world limits
Demonstrations and field trials expanded, making robustness, recovery and teleoperation dependence easier to evaluate.
What changed
Commercial intent
More organizations described paths toward deployable systems.
Intent is broadening; delivery evidence remains decisive.
System integration
Compute, control, sensing and workflows are increasingly discussed together.
Competition is moving from components toward complete operating stacks.
Evidence quality
Company targets continued to outnumber independently measured deployments.
Claims and actuals must remain separate.
Regional participation
All six tracked regions contributed public signals.
The ecosystem is global but commercialization paths differ.
20 key developments
01 · China · 2026-04-02
Unitree Robotics: developer ecosystem enters the monthly evidence set
The April retrospective records public activity from Unitree Robotics under developer ecosystem. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
02 · China · 2026-04-03
UBTECH Robotics: manufacturing partnership enters the monthly evidence set
The April retrospective records public activity from UBTECH Robotics under manufacturing partnership. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
03 · China · 2026-04-05
AgiBot: field evaluation enters the monthly evidence set
The April retrospective records public activity from AgiBot under field evaluation. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
04 · China · 2026-04-06
XPeng Robotics: data infrastructure enters the monthly evidence set
The April retrospective records public activity from XPeng Robotics under data infrastructure. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
05 · USA · 2026-04-08
NVIDIA Robotics: component integration enters the monthly evidence set
The April retrospective records public activity from NVIDIA Robotics under component integration. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
06 · USA · 2026-04-09
Figure AI: commercial offer enters the monthly evidence set
The April retrospective records public activity from Figure AI under commercial offer. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
07 · USA · 2026-04-11
Agility Robotics: policy programme enters the monthly evidence set
The April retrospective records public activity from Agility Robotics under policy programme. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
08 · USA · 2026-04-12
Apptronik: research result enters the monthly evidence set
The April retrospective records public activity from Apptronik under research result. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
09 · Europe · 2026-04-13
NEURA Robotics: service workflow enters the monthly evidence set
The April retrospective records public activity from NEURA Robotics under service workflow. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
10 · Europe · 2026-04-15
PAL Robotics: mobility and manipulation enters the monthly evidence set
The April retrospective records public activity from PAL Robotics under mobility and manipulation. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
11 · Europe · 2026-04-16
European Commission: fleet operations enters the monthly evidence set
The April retrospective records public activity from European Commission under fleet operations. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
12 · Europe · 2026-04-18
International Federation of Robotics: human-robot collaboration enters the monthly evidence set
The April retrospective records public activity from International Federation of Robotics under human-robot collaboration. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
13 · Japan · 2026-04-19
Toyota Research Institute: supply-chain expansion enters the monthly evidence set
The April retrospective records public activity from Toyota Research Institute under supply-chain expansion. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
14 · Japan · 2026-04-21
Kawasaki Robotics: market evidence enters the monthly evidence set
The April retrospective records public activity from Kawasaki Robotics under market evidence. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
15 · Japan · 2026-04-22
SoftBank Robotics: standards activity enters the monthly evidence set
The April retrospective records public activity from SoftBank Robotics under standards activity. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
16 · South Korea · 2026-04-23
Hyundai Motor Group: platform update enters the monthly evidence set
The April retrospective records public activity from Hyundai Motor Group under platform update. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
17 · South Korea · 2026-04-25
ROBOTIS: industrial deployment enters the monthly evidence set
The April retrospective records public activity from ROBOTIS under industrial deployment. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
18 · South Korea · 2026-04-26
KIMM: robot-learning release enters the monthly evidence set
The April retrospective records public activity from KIMM under robot-learning release. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
19 · India · 2026-04-28
Addverb: funding and capacity enters the monthly evidence set
The April retrospective records public activity from Addverb under funding and capacity. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
20 · India · 2026-04-29
Ati Motors: safety and governance enters the monthly evidence set
The April retrospective records public activity from Ati Motors under safety and governance. The source is retained for traceability; claims are not treated as verified deployment outcomes without independent evidence.
DXresearch interpretation: this signal contributes to the month’s theme—public trials expose real-world limits—but significance depends on delivered systems, repeatable task performance and disclosed operating evidence.
Market Sentiment, Evidence & Outlook
Balanced, Proof-Seeking
Evidence note: retrospective source anchors, company claims, reported actuals, research results and estimates must not be conflated.
Outlook: watch delivered systems, safe recovery, repeatable tasks, service capacity and verified economics.
Annual Global Humanoid Shipment Scenarios, 2025–2040
| Year | Conservative | Base | Accelerated |
|---|---|---|---|
| 2025 | 18,000 | 30,000 | 45,000 |
| 2026 | 65,000 | 125,000 | 180,000 |
| 2027 | 115,000 | 240,000 | 380,000 |
| 2028 | 190,000 | 430,000 | 750,000 |
| 2029 | 300,000 | 720,000 | 1,350,000 |
| 2030 | 460,000 | 1,150,000 | 2,250,000 |
| 2031 | 680,000 | 1,750,000 | 3,500,000 |
| 2032 | 950,000 | 2,500,000 | 5,100,000 |
| 2033 | 1,300,000 | 3,450,000 | 7,100,000 |
| 2034 | 1,700,000 | 4,600,000 | 9,500,000 |
| 2035 | 2,150,000 | 5,900,000 | 12,300,000 |
| 2036 | 2,650,000 | 7,350,000 | 15,500,000 |
| 2037 | 3,200,000 | 8,900,000 | 19,200,000 |
| 2038 | 3,800,000 | 10,500,000 | 23,400,000 |
| 2039 | 4,500,000 | 12,200,000 | 28,100,000 |
| 2040 | 5,200,000 | 14,000,000 | 33,500,000 |
Editorial scenarios, not reported actuals.
Weekly news infographic
